These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16920233)

  • 1. Enhanced immunisation and expression strategies using bacterial spores as heat-stable vaccine delivery vehicles.
    Uyen NQ; Hong HA; Cutting SM
    Vaccine; 2007 Jan; 25(2):356-65. PubMed ID: 16920233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial spores as vaccine vehicles.
    Duc le H; Hong HA; Fairweather N; Ricca E; Cutting SM
    Infect Immun; 2003 May; 71(5):2810-8. PubMed ID: 12704155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A probiotic treatment increases the immune response induced by the nasal delivery of spore-adsorbed TTFC.
    Santos FDS; Mazzoli A; Maia AR; Saggese A; Isticato R; Leite F; Iossa S; Ricca E; Baccigalupi L
    Microb Cell Fact; 2020 Feb; 19(1):42. PubMed ID: 32075660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis.
    Robinson K; Chamberlain LM; Schofield KM; Wells JM; Le Page RW
    Nat Biotechnol; 1997 Jul; 15(7):653-7. PubMed ID: 9219268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Display of heterologous antigens on the Bacillus subtilis spore coat using CotC as a fusion partner.
    Mauriello EM; Duc le H; Isticato R; Cangiano G; Hong HA; De Felice M; Ricca E; Cutting SM
    Vaccine; 2004 Mar; 22(9-10):1177-87. PubMed ID: 15003646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, heat stability and safety of intranasally administered Bacillus subtilis spore or vegetative cell vaccines expressing tetanus toxin fragment C.
    Lee S; Belitsky BR; Brown DW; Brinker JP; Kerstein KO; Herrmann JE; Keusch GT; Sonenshein AL; Tzipori S
    Vaccine; 2010 Sep; 28(41):6658-65. PubMed ID: 20709005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice.
    Medaglini D; Ciabattini A; Spinosa MR; Maggi T; Marcotte H; Oggioni MR; Pozzi G
    Vaccine; 2001 Feb; 19(15-16):1931-9. PubMed ID: 11228363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization against anthrax using Bacillus subtilis spores expressing the anthrax protective antigen.
    Duc le H; Hong HA; Atkins HS; Flick-Smith HC; Durrani Z; Rijpkema S; Titball RW; Cutting SM
    Vaccine; 2007 Jan; 25(2):346-55. PubMed ID: 17007969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual immunization with an engineered Bacillus subtilis strain expressing tetanus toxin fragment C induces systemic and mucosal immune responses in piglets.
    Amuguni H; Lee S; Kerstein K; Brown D; Belitsky B; Herrmann J; Keusch G; Sonenshein A; Tzipori S
    Microbes Infect; 2012 May; 14(5):447-56. PubMed ID: 22198093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral priming of mice by recombinant spores of Bacillus subtilis.
    Ciabattini A; Parigi R; Isticato R; Oggioni MR; Pozzi G
    Vaccine; 2004 Oct; 22(31-32):4139-43. PubMed ID: 15474704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the immune responses induced by local immunizations with recombinant Lactobacillus plantarum producing tetanus toxin fragment C in different cellular locations.
    Reveneau N; Geoffroy MC; Locht C; Chagnaud P; Mercenier A
    Vaccine; 2002 Mar; 20(13-14):1769-77. PubMed ID: 11906764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface display of recombinant proteins on Bacillus subtilis spores.
    Isticato R; Cangiano G; Tran HT; Ciabattini A; Medaglini D; Oggioni MR; De Felice M; Pozzi G; Ricca E
    J Bacteriol; 2001 Nov; 183(21):6294-301. PubMed ID: 11591673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against tetanus toxin after intragastric administration of two recombinant lactic acid bacteria: impact of strain viability and in vivo persistence.
    Grangette C; Müller-Alouf H; Geoffroy M; Goudercourt D; Turneer M; Mercenier A
    Vaccine; 2002 Sep; 20(27-28):3304-9. PubMed ID: 12213400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacillus subtilis: a temperature resistant and needle free delivery system of immunogens.
    Amuguni H; Tzipori S
    Hum Vaccin Immunother; 2012 Jul; 8(7):979-86. PubMed ID: 22699442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germination-independent induction of cellular immune response by Bacillus subtilis spores displaying the C fragment of the tetanus toxin.
    Mauriello EM; Cangiano G; Maurano F; Saggese V; De Felice M; Rossi M; Ricca E
    Vaccine; 2007 Jan; 25(5):788-93. PubMed ID: 17028079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Helicobacter pylori urease B on the surface of Bacillus subtilis spores.
    Zhou Z; Gong S; Li XM; Yang Y; Guan R; Zhou S; Yao S; Xie Y; Ou Z; Zhao J; Liu Z
    J Med Microbiol; 2015 Jan; 64(Pt 1):104-110. PubMed ID: 25355934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C.
    Robinson K; Chamberlain LM; Lopez MC; Rush CM; Marcotte H; Le Page RW; Wells JM
    Infect Immun; 2004 May; 72(5):2753-61. PubMed ID: 15102785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Bacillus subtilis spores for the delivery of Mycobacterium tuberculosis Ag85B-CFP10 secretory antigens.
    Das K; Thomas T; Garnica O; Dhandayuthapani S
    Tuberculosis (Edinb); 2016 Dec; 101S():S18-S27. PubMed ID: 27727129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of the ganglioside binding activity of the tetanus toxin HC fragment destroys immunogenicity: implications for development of novel tetanus vaccines.
    Qazi O; Sesardic D; Tierney R; Söderbäck Z; Crane D; Bolgiano B; Fairweather N
    Infect Immun; 2006 Aug; 74(8):4884-91. PubMed ID: 16861677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combination of recombinant and non-recombinant Bacillus subtilis spore display technology for presentation of antigen and adjuvant on single spore.
    Potocki W; Negri A; Peszyńska-Sularz G; Hinc K; Obuchowski M; Iwanicki A
    Microb Cell Fact; 2017 Sep; 16(1):151. PubMed ID: 28899372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.